Dan Huang

Dan Huang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2022 in Molecular Cell
Verified
Journal Article
Closed access
DHDan Huang
Dan Huang
WKW. Lee Kraus
W. Lee Kraus

1 April 2013 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FZFengxiao Zhang
Fengxiao Zhang
YWYan Wang
Yan Wang
LWLin Wang
Lin Wang
XLXi Luo
Xi Luo
KHKun Huang
Kun Huang
KHKai Huang
Kai Huang
Activation of nuclear receptor estrogen receptor α (ERα) exerts cardiovascular protective effects by modulating the expression of ERα target genes. However, the underlying mechanism remains unclear. PARP1 is a ubiquitous multifunctional nuclear enzyme. In this study, we examined the interplay between PARP1 and ERα, and identified PARP1 as an important regulator of ERα-dependent transcription. We showed that PARP1 could directly bind to ERα, and ERα could be poly(ADP-ribosyl)ated by PARP1. Poly(ADP-ribosyl)ation increased ERα binding to estrogen response element (ERE) present in the promoter of target genes and promoted ERα-mediated gene transcription. Estradiol, the ligand of ERα, increased PARP enzymatic activity and enhanced poly(ADP-ribosyl)ation of ERα. Upon treatment with estradiol, ERα binding to ERE- and ERα-dependent gene expression was dramatically increased in cultured vascular smooth muscle cells (VSMCs). Inhibition of PARP1 by PARP inhibitor or PARP1 siRNA decreased ERα binding to ERE and prevented ERα-dependent gene transcription in VSMCs. Further studies revealed that PARP1 served as an indispensible component for the formation of the ERα-ERE complex by directly interacting with ERα. Thus, our results identify PARP1 as a key regulator of ERα in controlling ERα transactivation.

28 February 2024 in Environmental Impact Assessment Review
Verified
Journal Article
Closed access
YLYanchi Lu
Yanchi Lu
DHDan Huang
Dan Huang
ZTZhaomin Tong
Zhaomin Tong
YLYaolin Liu
Yaolin Liu
JHJianhua He
Jianhua He
YLYanfang Liu
Yanfang Liu

13 January 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RARupesh H. Amin
Rupesh H. Amin
DCDragana Cado
Dragana Cado
HNHector Nolla
Hector Nolla
DHDan Huang
Dan Huang
SSSusan A. Shinton
Susan A. Shinton
MSMark S. Schlissel
Mark S. Schlissel
Allelic exclusion of Ig gene expression is necessary to limit the number of functional receptors to one per B cell. The mechanism underlying allelic exclusion is unknown. Because germline transcription of Ig and TCR loci is tightly correlated with rearrangement, we created two novel knock-in mice that report transcriptional activity of the Jκ germline promoters in the Igκ locus. Analysis of these mice revealed that germline transcription is biallelic and occurs in all pre-B cells. Moreover, we found that the two germline promoters in this region are not equivalent but that the distal promoter accounts for the vast majority of observed germline transcript in pre-B cells while the activity of the proximal promoter increases later in development. Allelic exclusion of the Igκ locus thus occurs at the level of rearrangement, but not germline transcription.

26 April 2022 in Cancer Research
Verified
Journal Article
Open access
PDF file
DHDan Huang
Dan Huang
CCCristel Camacho
Cristel Camacho
SMSara Martire
Sara Martire
ANAnusha Nagari
Anusha Nagari
RSRohit Setlem
Rohit Setlem
WKW. Lee Kraus
W. Lee Kraus
Recent studies have identified cancer-associated mutations in histone genes that lead to the expression of mutant versions of core histones called oncohistones. Many oncohistone mutations occur at Asp and Glu residues, two amino acids known to be ADP-ribosylated (ADPRylated) by PARP1. We screened 25 Glu or Asp oncohistone mutants for their effects on cell growth in breast and ovarian cancer cells. Ectopic expression of six mutants of three different core histones (H2B, H3, and H4) altered cell growth in at least two different cell lines. Two of these sites, H2B-D51 and H4-D68, were indeed sites of ADPRylation in wild-type (unmutated) histones, and mutation of these sites inhibited ADPRylation. Mutation of H2B-D51 dramatically altered chromatin accessibility at enhancers and promoters, as well as gene expression outcomes, whereas mutation of H4-D68 did not. Additional biochemical, cellular, proteomic, and genomic analyses demonstrated that ADPRylation of H2B-D51 inhibits p300-mediated acetylation of H2B at many Lys residues. In breast cancer cell xenografts in mice, H2B-D51A promoted tumor growth, but did not confer resistance to the cytotoxic effects of PARP inhibition. Collectively, these results demonstrate that functional Asp and Glu ADPRylation sites on histones are mutated in cancers, allowing cancer cells to escape the growth-regulating effects of post-translational modifications via distinct mechanisms. Significance: This study identifies cancer-driving mutations in histones as sites of PARP1–mediated ADP-ribosylation in breast and ovarian cancers, providing a molecular pathway by which cancers may subvert the growth-regulating effects of PARP1.

15 December 2022
Verified
Book Chapter
Closed access
PDF file
DHDan Huang
Dan Huang
AEAndrea D. Edwards
Andrea D. Edwards
XGXuan Gong
Xuan Gong
WKW. Lee Kraus
W. Lee Kraus